The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role
Open accessAbstract
The vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) play crucial roles in vasculogenesis and angiogenesis. Angiogenesis is an important mechanism in many physiological and pathological processes, and is involved in endothelial cell proliferation, migration, and survival, then leads to further tubulogenesis, and finally promotes formation of vessels. This series of signaling cascade pathways are precisely mediated by VEGF/VEGFR-2 system. The VEGF binding to the IgD2 and IgD3 of VEGFR-2 induces the dimerization of the receptor, subsequently the activation and trans-autophosphorylation of the tyrosine kinase, and then the initiation of the intracellular signaling cascades. Finally the VEGF-activated VEGFR-2 stimulates and mediates variety of signaling transduction, biological responses, and pathological processes in angiogenesis. Several crucial phosphorylated sites Tyr801, Try951, Try1175, and Try1214 in the VEGFR-2 intracellular domains mediate several key signaling processes including PLCγ-PKC, TSAd-Src-PI3K-Akt, SHB-FAK-paxillin, SHB-PI3K-Akt, and NCK-p38-MAPKAPK2/3 pathways. Based on the molecular structure and signaling pathways of VEGFR-2, the strategy of the VEGFR-2-targeted therapy should be considered to employ in the treatment of the VEGF/VEGFR-2-associated diseases by blocking the VEGF/VEGFR-2 signaling pathway, inhibiting VEGF and VEGFR-2 gene expression, blocking the binding of VEGF and VEGFR-2, and preventing the proliferation, migration, and survival of vascular endothelial cells expressing VEGFR-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Shibuya, M. (2011) · Genes & Cancer · doi:10.1177/1947601911423031 · Cited by 1,748
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Signal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Autophagy and autophagy-related proteins in cancer
Li, X., He, S., & Ma, B. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1138-4 · Cited by 1,613
Self-citationPI3K/AKT/mTOR Pathway in Angiogenesis
Karar, J., & Maity, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00051 · Cited by 1,461
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039
Ten years of anti-vascular endothelial growth factor therapy
Ferrara, N., & Adamis, A. P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.17 · Cited by 1,030
Holmes, K., Roberts, O. L., Thomas, A. M., & Cross, M. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.05.013 · Cited by 1,020
Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
PI 3-kinase, Akt and cell survival
Downward, J. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.01.002 · Cited by 783
Takahashi, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2768 · Cited by 749
Molecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A., & Lyons, K. M. (2003) · Development · doi:10.1242/dev.00505 · Cited by 713
Ma, Q., Ineichen, B. V., Detmar, M., & Proulx, S. T. (2017) · Nature Communications · doi:10.1038/s41467-017-01484-6 · Cited by 690
The Role of Angiogenesis in Cancer Treatment
Rajabi, M., & Mousa, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020034 · Cited by 656
Targeting VEGF/VEGFR to modulate antitumor immunity
Yang, J., Yan, J., & Liu, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00978 · Cited by 646
Hooper, A. T., Butler, J. M., Nolan, D. J., Kranz, A., Iida, K., Kobayashi, M., Kopp, H.-G., Shido, K., Petit, I., Yanger, K., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.006 · Cited by 641
McTigue, M., Murray, B. W., Chen, J. H., Deng, Y.-L., Solowiej, J., & Kania, R. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207759109 · Cited by 592
Takahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
Graupera, M., Guillermet-Guibert, J., Foukas, L. C., Phng, L.-K., Cain, R. J., Salpekar, A., Pearce, W., Meek, S., Millan, J., Cutillas, P. R., et al. (2008) · Nature · doi:10.1038/nature06892 · Cited by 520
Croci, D. O., Cerliani, J. P., Dalotto-Moreno, T., Méndez-Huergo, S. P., Mascanfroni, I. D., Dergan-Dylon, S., Toscano, M. A., Caramelo, J. J., García-Vallejo, J. J., Ouyang, J., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.043 · Cited by 505
Structure and Function of VEGF/VEGF-receptor System Involved in Angiogenesis.
Shibuya, M. (2001) · Cell Structure and Function · doi:10.1247/csf.26.25 · Cited by 504
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
Dias, S., Hattori, K., Zhu, Z., Heissig, B., Choy, M., Lane, W., Wu, Y., Chadburn, A., Hyjek, E., Gill, M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8978 · Cited by 434
The role of VEGF receptors in angiogenesis; complex partnerships
Cébe-Suarez, S., Zehnder-Fjällman, A., & Ballmer-Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5426-3 · Cited by 405
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF–VEGFR2 signalling
Benedito, R., Rocha, S. F., Woeste, M., Zamykal, M., Radtke, F., Casanovas, O., Duarte, A., Pytowski, B., & Adams, R. H. (2012) · Nature · doi:10.1038/nature10908 · Cited by 362
Diabetic Retinopathy and Angiogenesis
Crawford, T., Alfaro III, D., Kerrison, J., & Jablon, E. (2009) · Current Diabetes Reviews · doi:10.2174/157339909787314149 · Cited by 350
Ferrari, G., Cook, B. D., Terushkin, V., Pintucci, G., & Mignatti, P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21706 · Cited by 340
Wybenga-Groot, L. E., Baskin, B., Ong, S. H., Tong, J., Pawson, T., & Sicheri, F. (2001) · Cell · doi:10.1016/s0092-8674(01)00496-2 · Cited by 338
Moriki, T., Maruyama, H., & Maruyama, I. N. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4923 · Cited by 337
Vascular endothelial growth factor signaling in development and disease
Karaman, S., Leppänen, V.-M., & Alitalo, K. (2018) · Development · doi:10.1242/dev.151019 · Cited by 335
Takahashi, T., & Shibuya, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201047 · Cited by 308
Zeng, H., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103213200 · Cited by 294
VEGF receptor‐2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis
Matsumoto, T., Bohman, S., Dixelius, J., Berge, T., Dimberg, A., Magnusson, P., Wang, L., Wikner, C., Qi, J. H., Wernstedt, C., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600709 · Cited by 292
Elvert, G., Kappel, A., Heidenreich, R., Englmeier, U., Lanz, S., Acker, T., Rauter, M., Plate, K., Sieweke, M., Breier, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211298200 · Cited by 271
Holmqvist, K., Cross, M. J., Rolny, C., Hägerkvist, R., Rahimi, N., Matsumoto, T., Claesson-Welsh, L., & Welsh, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312729200 · Cited by 265
Fuh, G., Li, B., Crowley, C., Cunningham, B., & Wells, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11197 · Cited by 259
Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
Fallah, A., Sadeghinia, A., Kahroba, H., Samadi, A., Heidari, H. R., Bradaran, B., Zeinali, S., & Molavi, O. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.022 · Cited by 259
Interleukin-6 Stimulates Defective Angiogenesis
Gopinathan, G., Milagre, C., Pearce, O. M. T., Reynolds, L. E., Hodivala-Dilke, K., Leinster, D. A., Zhong, H., Hollingsworth, R. E., Thompson, R., Whiteford, J. R., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1227 · Cited by 249
Fibroblast growth factors: key players in regeneration and tissue repair.
Maddaluno, L., Urwyler, C., & Werner, S. (2017) · Development · doi:10.1242/dev.152587 · Cited by 241
Masoumi Moghaddam, S., Amini, A., Morris, D. L., & Pourgholami, M. H. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9337-5 · Cited by 228
Lamalice, L., Houle, F., Jourdan, G., & Huot, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207034 · Cited by 224
A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis
Klagsbrun, M., & Eichmann, A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.002 · Cited by 221
LeCouter, J., Zlot, C., Tejada, M., Peale, F., & Ferrara, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407697101 · Cited by 219
VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy
Rahimi, N. (2006) · Frontiers in Bioscience · doi:10.2741/1839 · Cited by 214
Shen, B.-Q., Lee, D. Y., Gerber, H.-P., Keyt, B. A., Ferrara, N., & Zioncheck, T. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29979 · Cited by 211
Siveen, K. S., Prabhu, K., Krishnankutty, R., Kuttikrishnan, S., Tsakou, M., Alali, F. Q., Dermime, S., Mohammad, R. M., & Uddin, S. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666170105124038 · Cited by 209
Marrelli, A., Cipriani, P., Liakouli, V., Carubbi, F., Perricone, C., Perricone, R., & Giacomelli, R. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.020 · Cited by 205
Structural determinants of growth factor binding and specificity by VEGF receptor 2
Leppänen, V.-M., Prota, A. E., Jeltsch, M., Anisimov, A., Kalkkinen, N., Strandin, T., Lankinen, H., Goldman, A., Ballmer-Hofer, K., & Alitalo, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914318107 · Cited by 177
Lamalice, L., Houle, F., & Huot, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603928200 · Cited by 177
Wong, C., & Jin, Z.-G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503198200 · Cited by 176
Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates
Lee, M. Y., Luciano, A. K., Ackah, E., Rodriguez-Vita, J., Bancroft, T. A., Eichmann, A., Simons, M., Kyriakides, T. R., Morales-Ruiz, M., & Sessa, W. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408472111 · Cited by 176
Contribution of marrow-derived progenitors to vascular and cardiac regeneration
Rafii, S., Meeus, S., Dias, S., Hattori, K., Heissig, B., Shmelkov, S. V., Rafii, D. C., & Lyden, D. C. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0285 · Cited by 173
Focal adhesion kinase and tumour angiogenesis
Lechertier, T., & Hodivala‐Dilke, K. (2012) · The Journal of Pathology · doi:10.1002/path.3018 · Cited by 169
Differential roles of PDGFR‐α and PDGFR‐β in angiogenesis and vessel stability
Zhang, J., Cao, R., Zhang, Y., Jia, T., Cao, Y., & Wahlberg, E. (2009) · The FASEB Journal · doi:10.1096/fj.08-113860 · Cited by 162
Structure of a VEGF–VEGF receptor complex determined by electron microscopy
Ruch, C., Skiniotis, G., Steinmetz, M. O., Walz, T., & Ballmer‐Hofer, K. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1202 · Cited by 155
Shinkai, A., Ito, M., Anazawa, H., Yamaguchi, S., Shitara, K., & Shibuya, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31283 · Cited by 155
Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization
Brozzo, M. S., Bjelić, S., Kisko, K., Schleier, T., Leppänen, V., Alitalo, K. K., Winkler, F. K., & Ballmer‐Hofer, K. (2011) · Blood · doi:10.1182/blood-2011-11-390922 · Cited by 154
Bellon, A., Luchino, J., Haigh, K., Rougon, G., Haigh, J. J., Chauvet, S., & Mann, F. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.006 · Cited by 150
Stopeck, A., Sheldon, M., Vahedian, M., Cropp, G. F., Gosalia, R., & Hannah, A. L. (2002) · PubMed · Cited by 150
VEGFR-2 conformational switch in response to ligand binding
Sarabipour, S., Ballmer‐Hofer, K., & Hristova, K. A. (2016) · eLife · doi:10.7554/elife.13876 · Cited by 147
Duval, M., Bœuf, F. L., Huot, J., & Gratton, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0467 · Cited by 143
Angiogenesis in Inflammatory Bowel Disease
Alkim, C. A., Alkım, H., Köksal, A. R., Boğa, S., & Şen, İ. (2015) · International Journal of Inflammation · doi:10.1155/2015/970890 · Cited by 140
The Role of PDGFs and PDGFRs in Colorectal Cancer
Manzat-Saplacan, R. M., Bălăcescu, L., Gherman, C. D., Chira, R. I., Anca, C., Mircea, P. A., Lisencu, C. I., & Bălăcescu, O. (2017) · Mediators of Inflammation · doi:10.1155/2017/4708076 · Cited by 139
Kendall, R. L., Rutledge, R. Z., Mao, X., Tebben, A. J., Hungate, R. W., & Thomas, K. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6453 · Cited by 136
Zhang, J., & Hughes, S. (2006) · The Journal of Pathology · doi:10.1002/path.1937 · Cited by 135
Angiogenesis in diabetes and obesity
Cheng, R., & Ma, J. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9310-7 · Cited by 133
VEGFR and Type-V RTK Activation and SignalingPreprint
Shibuya, M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009092 · Cited by 129
Developmental and pathological angiogenesis in the central nervous system
Vallon, M., Chang, J., Zhang, J. H., & Kuo, C. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1625-0 · Cited by 126
Structure and function of vascular endothelial growth factor and its receptor system
Park, S. A., Jeong, M. S., Ha, K., & Jang, S. B. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.2.233 · Cited by 125
VEGF Regulates Cell Behavior during Vasculogenesis
Drake, C. J., LaRue, A. C., Ferrara, N., & Little, C. D. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9744 · Cited by 124
Transmembrane Peptides as Inhibitors of ErbB Receptor Signaling
Bennasroune, A., Fickova, M., Gardin, A., Dirrig‐Grosch, S., Aunis, D., Crémel, G., & Hubert, P. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-10-0753 · Cited by 115
Basagiannis, D., Zografou, S., Murphy, C., Fotsis, T., Morbidelli, L., Ziche, M., Bleck, C. K. E., Mercer, J., & Christoforidis, S. (2016) · Journal of Cell Science · doi:10.1242/jcs.188219 · Cited by 115
Laramée, M., Chabot, C., Cloutier, M., Stenne, R., Holgado-Madruga, M., Wong, A. J., & Royal, I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m611327200 · Cited by 105
Yang, Y., Xie, P., Opatowsky, Y., & Schlessinger, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914052107 · Cited by 102
Gliki, G., ABU-GHAZALEH, R., Jezequel, S., Wheeler-Jones, C. P. D., & Zachary, I. C. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530503 · Cited by 100
Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin
Smith, R., Ninchoji, T., Gordon, E. J., André, H., Dejana, E., Vestweber, D., Kvanta, A., & Claesson, L. (2020) · eLife · doi:10.7554/elife.54056 · Cited by 100
Vascular Endothelial Growth Factor (VEGF) Pathway
Nilsson, M. B., & Heymach, J. V. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30404-4 · Cited by 95
Kaga, T., Kawano, H., Sakaguchi, M., Nakazawa, T., Taniyama, Y., & Morishita, R. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.002 · Cited by 93
Blanes, M. G., Oubaha, M., Rautureau, Y., & Gratton, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609048200 · Cited by 86
Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation
Chen, X., Yang, G., Song, J., Xu, H. J., Li, D., Goldsmith, J. D., Zeng, H., Parsons‐Wingerter, P. A., Reinecker, H., & Kelly, C. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064227 · Cited by 86
Role of Platelet-Derived Growth Factors in Angiogenesis and Alveogenesis
Lindahl, P., Boström, H., Karlsson, L., Hellström, M., Kalén, M., & Betsholtz, C. (1999) · Current topics in pathology · doi:10.1007/978-3-642-58456-5_4 · Cited by 85
Receptor-selective Variants of Human Vascular Endothelial Growth Factor
Li, B., Fuh, G., Meng, G., Xin, X., Gerritsen, M. E., Cunningham, B. C., & de Vos, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002015200 · Cited by 85
Chandler, K. B., Leon, D. R., Kuang, J., Meyer, R., Rahimi, N., & Costello, C. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008643 · Cited by 83
WARNER, A. J., Lopez‐Dee, J., KNIGHT, E. L., Feramisco, J. R., & Prigent, S. A. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470501 · Cited by 82
EphrinB2/EphB4 signaling regulates non‐sprouting angiogenesis by VEGF
Groppa, E., Brkić, Š., Uccelli, A., Wirth, G., Korpisalo, P., Filippova, M., Dasen, B., Sacchi, V., Muraro, M. G., Trani, M., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745054 · Cited by 82
The 2.7 Å Crystal Structure of the Autoinhibited Human c-Fms Kinase Domain
Walter, M., Lucet, I. S., Patel, O., Broughton, S. E., Bamert, R. S., Williams, N. K., Fantino, E., Wilks, A. F., & Rossjohn, J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.01.036 · Cited by 81
Differential Regulation of VEGF Signaling by PKC-α and PKC-ε in Endothelial Cells
Rask‐Madsen, C., & King, G. L. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162842 · Cited by 81
Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis
Yehya, A. H. S., Asif, M., Petersen, S. H., Subramaniam, A. V., Kono, K., Majid, A. M. S. A., & Oon, C. E. (2018) · Medicina · doi:10.3390/medicina54010008 · Cited by 81
CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia
Jang, W., Park, J., Kwon, A., Choi, H., Kim, J., Lee, D., Han, E., Jekarl, D. W., Chae, H., Han, K., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0195-x · Cited by 81
Iwasaki, A. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2003.11.031 · Cited by 75
Angiopoietin-Tie Signaling Pathway in Endothelial Cells: A Computational Model
Zhang, Y., Kontos, C. D., Annex, B. H., & Popel, A. S. (2019) · iScience · doi:10.1016/j.isci.2019.10.006 · Cited by 74
Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2
Chandler, K. B., Leon, D. R., Meyer, R., Rahimi, N., & Costello, C. E. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00738 · Cited by 53
Solowiej, J. E., Bergqvist, S., McTigue, M. A., Marrone, T. J., Quenzer, T. L., Cobbs, M., Ryan, K., Kania, R. S., Diehl, W. C., & Murray, B. W. (2009) · Biochemistry · doi:10.1021/bi900522y · Cited by 52
Manni, S., Mineev, K. S., Usmanova, D. R., Lyukmanova, E. N., Shulepko, M. A., Kirpichnikov, M. P., Winter, J., Matkovic, M., Deupí, X., Arseniev, A. S., et al. (2014) · Structure · doi:10.1016/j.str.2014.05.010 · Cited by 49
Structural bases of physiological functions and roles of the vacuolar H+-ATPase
Ma, B., Xiang, Y., & An, L. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.03.003 · Cited by 44
Self-citationVEGFR2-PLCγ1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cells
Sase, H., Watabe, T., Kawasaki, K., Miyazono, K., & Miyazawa, K. (2009) · Journal of Cell Science · doi:10.1242/jcs.049908 · Cited by 43
Marchand, G. S., Noiseux, N., Tanguay, J., & Sirois, M. G. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2002.282.1.h194 · Cited by 42
Ji, L., Wu, M., & Li, Z. (2018) · Molecules · doi:10.3390/molecules23082047 · Cited by 37
VEGF/VEGFR2 signaling regulates hippocampal axon branching during development
Luck, R., Urban, S., Karakatsani, A., Harde, E., Sambandan, S., Nicholson, L., Haverkamp, S., Mann, R., Martín-Villalba, A., Schuman, E. M., et al. (2019) · eLife · doi:10.7554/elife.49818 · Cited by 36
Volz, C., Breid, S., Selenz, C., Zaplatina, A., Golfmann, K., Meder, L., Dietlein, F., Borchmann, S., Chatterjee, S., Siobal, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107568 · Cited by 30
Wang, L., Ge, H., Peng, L., et al. (2019) · Clinical Cardiology · doi:10.1002/clc.23233 · Cited by 21
Manni, S., Kisko, K., Schleier, T., Missimer, J., & Ballmer‐Hofer, K. (2014) · The FASEB Journal · doi:10.1096/fj.14-256206 · Cited by 19
SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175
Kim, D. Y., Park, J. A., Kim, Y., Noh, M., Park, S., Lie, E., Kim, E., Kim, Y., & Kwon, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201802516rr · Cited by 17
Han, S., Tan, C. M., Ding, J., Wang, J., Ma’ayan, A., & Gouon–Evans, V. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.06.004 · Cited by 15
6′-Sialylgalactose inhibits vascular endothelial growth factor receptor 2-mediated angiogenesis
Chung, T., Kim, E.-Y., Choi, H., Han, C. W., Jang, S. B., Kim, K., Jin, L., Koh, Y. J., & Ha, K. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0311-6 · Cited by 15
Yin, Z., Gong, G., Zhu, C., Wang, B., Sun, C., Liu, X., & Yin, J. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001491 · Cited by 10
Biochemical and Conformational Characterization of Recombinant VEGFR2 Domain 7
Stasi, R. D., Diana, D., Rosa, L. D., Fattorusso, R., & D’Andrea, L. D. (2019) · Molecular Biotechnology · doi:10.1007/s12033-019-00211-4 · Cited by 4
Cited by
Lee, C., Kim, M.-J., Kumar, A., Lee, H.-W., Yang, Y., & Kim, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02249-0 · Cited by 365
The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF
Ghalehbandi, S., Yuzugulen, J., Pranjol, M. Z. I., & Pourgholami, M. H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175586 · Cited by 362
Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
Zhao, Q., Wu, Z. E., Li, B., & Li, F. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108256 · Cited by 57
Pellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10058-y · Cited by 33
Metadata
- Authors
- Wang, X., Bove, A. M., Simone, G., & Ma, B.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-16
- Volume
- 8
- Pages
- 599281-599281
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3099076257
- Cited by
- 442
- References
- 117
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.